These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25483220)

  • 1. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study.
    Grover SA; Kaouache M; Rempel P; Joseph L; Dawes M; Lau DC; Lowensteyn I
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):114-22. PubMed ID: 25483220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and Life Expectancy with and without Diabetes in Adults Aged 55 Years and Older in the Netherlands: A Prospective Cohort Study.
    Dhana K; Nano J; Ligthart S; Peeters A; Hofman A; Nusselder W; Dehghan A; Franco OH
    PLoS Med; 2016 Jul; 13(7):e1002086. PubMed ID: 27433939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies.
    Liu XM; Liu YJ; Zhan J; He QQ
    Eur J Epidemiol; 2015 Jan; 30(1):35-45. PubMed ID: 25421785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
    Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
    Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.
    Costanzo P; Cleland JG; Pellicori P; Clark AL; Hepburn D; Kilpatrick ES; Perrone-Filardi P; Zhang J; Atkin SL
    Ann Intern Med; 2015 May; 162(9):610-8. PubMed ID: 25938991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of weight loss and physical activity on all-cause mortality of overweight men and women.
    Østergaard JN; Grønbaek M; Schnohr P; Sørensen TI; Heitmann BL
    Int J Obes (Lond); 2010 Apr; 34(4):760-9. PubMed ID: 20065967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of obesity and physical activity in predicting mortality among men.
    Orsini N; Bellocco R; Bottai M; Pagano M; Michaelsson K; Wolk A
    J Intern Med; 2008 Nov; 264(5):442-51. PubMed ID: 18513340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Heart; 2009 Mar; 95(6):454-60. PubMed ID: 18697804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and disability: the effect of overweight and obesity.
    Walter S; Kunst A; Mackenbach J; Hofman A; Tiemeier H
    Int J Obes (Lond); 2009 Dec; 33(12):1410-8. PubMed ID: 19786964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
    Kramer CK; Zinman B; Retnakaran R
    Ann Intern Med; 2013 Dec; 159(11):758-69. PubMed ID: 24297192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underweight, overweight and obesity as risk factors for mortality and hospitalization.
    Ringbäck Weitoft G; Eliasson M; Rosén M
    Scand J Public Health; 2008 Mar; 36(2):169-76. PubMed ID: 18519281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of overall obesity and body fat distribution in predicting risk of mortality.
    Reis JP; Macera CA; Araneta MR; Lindsay SP; Marshall SJ; Wingard DL
    Obesity (Silver Spring); 2009 Jun; 17(6):1232-9. PubMed ID: 19197258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of functional aerobic capacity based on stress testing to predict outcomes in normal, overweight, and obese patients.
    Abudiab M; Aijaz B; Konecny T; Kopecky SL; Squires RW; Thomas RJ; Allison TG
    Mayo Clin Proc; 2013 Dec; 88(12):1427-34. PubMed ID: 24290116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
    van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counting the lifetime cost of obesity: Analysis based on national England data.
    Heald A; Stedman M; Fryer AA; Davies MB; Rutter MK; Gibson JM; Whyte M
    Diabetes Obes Metab; 2024 Apr; 26(4):1464-1478. PubMed ID: 38312024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of cardiovascular risk in overweight and obese people in England.
    de Lusignan S; Hague N; van Vlymen J; Dhoul N; Chan T; Thana L; Kumarapeli P
    Eur J Gen Pract; 2006; 12(1):19-29. PubMed ID: 16945868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.